Puma Biotech (PBYI) Misses Q4 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. KNX
10. QGEN

Go back to Puma Biotech (PBYI) Misses Q4 EPS by 3c

Puma Biotechnology (PBYI) PT Raised to $37 at RBC Capital

March 1, 2019 6:51 AM EST

RBC Capital analyst Kennen MacKay raised the price target on Puma Biotechnology (NASDAQ: PBYI) to $37.00 (from $29.00) while maintaining a Sector Perform rating following results.

MacKay called results "unexpectedly impressive" with +16% q/q growth versus a tepid +4% in Q3.

"Inventory confounds the... More